pubmed-article:16706765 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16706765 | lifeskim:mentions | umls-concept:C0041740 | lld:lifeskim |
pubmed-article:16706765 | lifeskim:mentions | umls-concept:C0079850 | lld:lifeskim |
pubmed-article:16706765 | lifeskim:mentions | umls-concept:C0149722 | lld:lifeskim |
pubmed-article:16706765 | lifeskim:mentions | umls-concept:C2739810 | lld:lifeskim |
pubmed-article:16706765 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
pubmed-article:16706765 | lifeskim:mentions | umls-concept:C0026183 | lld:lifeskim |
pubmed-article:16706765 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16706765 | pubmed:dateCreated | 2006-5-18 | lld:pubmed |
pubmed-article:16706765 | pubmed:abstractText | Mohs micrographic surgery (MMS) continues to become a more common and accepted treatment for lentigo maligna (LM) and lentigo maligna melanoma (LMM). The primary difficulty encountered lies in the accurate identification of atypical single melanocytes to determine tumor-free margins. Numerous methods have been used to better visualize single melanocytes, with varying results. We present our experience using Mel-5 immunostaining in MMS of LM and LMM. | lld:pubmed |
pubmed-article:16706765 | pubmed:language | eng | lld:pubmed |
pubmed-article:16706765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16706765 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16706765 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16706765 | pubmed:month | May | lld:pubmed |
pubmed-article:16706765 | pubmed:issn | 1076-0512 | lld:pubmed |
pubmed-article:16706765 | pubmed:author | pubmed-author:TopeWhitney... | lld:pubmed |
pubmed-article:16706765 | pubmed:author | pubmed-author:BhardwajSachi... | lld:pubmed |
pubmed-article:16706765 | pubmed:author | pubmed-author:LeePeter KPK | lld:pubmed |
pubmed-article:16706765 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16706765 | pubmed:volume | 32 | lld:pubmed |
pubmed-article:16706765 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16706765 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16706765 | pubmed:pagination | 690-6; discussion 696-7 | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:meshHeading | pubmed-meshheading:16706765... | lld:pubmed |
pubmed-article:16706765 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16706765 | pubmed:articleTitle | Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. | lld:pubmed |
pubmed-article:16706765 | pubmed:affiliation | University of Minnesota, Minneapolis, Minnesota 55455, USA. | lld:pubmed |
pubmed-article:16706765 | pubmed:publicationType | Journal Article | lld:pubmed |